Home » Topics » Regulatory

Regulatory
RSS

FDA approves Topamax for treatment of Lennox-Gastaut syndrome

Sep. 6, 2001

No Comments

Feridex I.V. sNDA deemed not approvable by FDA

Sep. 4, 2001

No Comments

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

No Comments

Study investigates Toprol-XL for reversal of cardiac remodeling

Sep. 4, 2001

No Comments

GSK claims new adenosine A1 agonist formulations for the treatment of pain

Aug. 29, 2001

No Comments

European approval granted for Ketek, Aventis' first-in-class antibiotic

Aug. 21, 2001

No Comments

FDA approves Natrecor for treatment of congestive heart failure

Aug. 14, 2001

No Comments

Roche receives first approval for PEGASYS

Aug. 10, 2001

No Comments

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Aug. 9, 2001

No Comments

Replagal receives European approval for Fabry's disease

Aug. 9, 2001

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

FDA approves Topamax for treatment of Lennox-Gastaut syndrome

Feridex I.V. sNDA deemed not approvable by FDA

Senju to develop ocular formulation of betotastine

Study investigates Toprol-XL for reversal of cardiac remodeling

GSK claims new adenosine A1 agonist formulations for the treatment of pain

European approval granted for Ketek, Aventis' first-in-class antibiotic

FDA approves Natrecor for treatment of congestive heart failure

Roche receives first approval for PEGASYS

BVdU reported to be useful for inhibiting the growth of hyperproliferative cells

Replagal receives European approval for Fabry's disease

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Regulatory RSS

Regulatory
RSS